Trial Details
COMPLETEDBasic Information
| Clinical ID | c375 |
|---|---|
| Identifier | NCT05596422 |
| Trial Title | A Study of Vedolizumab and Biologic Agents in Participants With Inflammatory Bowel Disease (IBD) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Disease (IBD)|Ulcerative Colitis|Crohn's Disease |
| Interventions | - |
Participant Information
| Sponsor | Takeda |
|---|---|
| City | Taichung |
| Country/Region | Taiwan |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2021-05-27 |
|---|---|
| Primary Completion Date | 2022-10-27 |
| Completion Date | 2022-12-08 |